CRDF icon

Cardiff Oncology
CRDF

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $1.68M invested in Cardiff Oncology in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

4.93% more ownership

Funds ownership: 7.39% → 12.33% (+4.9%)

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$544K
2
+$222K
3
+$67.7K
4
EP
Elkhorn Partners
Nebraska
+$50K
5
TSS
Two Sigma Securities
New York
+$26K

Top Sellers

1
-$7K
2
-$5.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$713K
2
$623K
3
$68K
4
$51K
5
$50K
6
$41K
7
$41K
8
$26K
9
$25K
10
$13K
11
$12K
12
$7K
13
$2K
14
$2K
15
$1K
16
$2
17
–